Dr. Vargas Lowy Child Neurology

09/20/2025

Walking into your child’s first neurology appointment can feel overwhelming — but a little preparation goes a long way. That's why we've gathered intel from caregivers, clinicians, and those who've been there to give you the best advice before you go!

These simple steps will help the doctor understand your child’s needs and make a plan that works for your family. You know your child best — and with the right prep, you can help their care team give the best care possible. 💙

👉 Save this post for your next visit!

Read more here: https://www.childneurologyfoundation.org/child-neurologist-new-visit-toolkit/

09/18/2025

09/18/2025

Seizures can strike without warning and being prepared can save a life. Whether you live with epilepsy or care for someone who does, knowing how to respond in a seizure emergency is critical. Learn more: bit.ly/4nJswV3

09/18/2025

Learn more about magnesium, as well as other supplements and herbs from your trusted health source, Andrew Weil, M.D.

08/30/2025

08/18/2025

08/18/2025

07/04/2025

06/21/2025

🧠✨ Mindfulness meets neurobiology in CM-MOH!

New study: “Neurotransmitter-related functional connectivity changes in serotonin and dopamine systems after mindfulness in medication overuse headache”

Can mindfulness reshape the brain in chronic migraine with medication overuse? This fMRI study says yes. After one year of mindfulness training:

🔹 ↑ Serotonin-related connectivity in caudate & accumbens
🔹 ↑ Dopamine-related connectivity in the right insula
🔸 These areas are key in pain, emotion, and addiction pathways.

🧘‍♀️ Findings suggest mindfulness may modulate neurotransmitter systems—offering a promising non-pharmacological approach to chronic pain and medication overuse.

📖 Read more: https://doi.org/10.1177/03331024251332561

06/21/2025

Dr. Weil's Anti-Inflammatory Diet and Food Pyramid is way of selecting and preparing anti-inflammatory foods based on scientific knowledge of how they can help your body maintain optimum health.

06/19/2025

🔍 Can atogepant offer relief for patients unresponsive to anti-CGRP mAbs?

The RESCUE study investigates the effectiveness of atogepant in individuals with episodic or chronic migraine who previously discontinued anti-CGRP monoclonal antibodies due to lack of efficacy.

🧠 Among 44 highly refractory cases:
✔️ 18.2% achieved ≥50% reduction in monthly headache days (MHDs)
✔️ Significant reductions were observed in MHDs, moderate-to-severe headache days, acute medication use, and HIT-6 scores
✔️ 59.1% reported some degree of global improvement
❗ Constipation was the most common adverse event (31.8%)

📌 These observational findings suggest that atogepant may be a viable preventive option for a difficult-to-treat population, meriting further prospective validation. RCTs are needed.

📖 Read the full article: https://doi.org/10.1177/03331024251346925

06/19/2025